1887

Abstract

Studies on the NS1 protein of flaviviruses have concluded that formation of a stable homodimer is required for virus replication. However, previous work has reported that substitution of a conserved proline by leucine at residue 250 in NS1 of Kunjin virus (KUNV) eliminated dimerization, but allowed virus replication to continue. To assess whether this substitution has similar effects on other flaviviruses, it was introduced into an infectious clone of Murray Valley encephalitis virus (MVEV). Consistent with studies of KUNV, the mutant virus (MVEV) produced high levels of monomeric NS1 and the NS1 homodimer could not be detected. In contrast, wild-type MVEV cultures contained predominantly dimeric NS1. Retarded virus growth in Vero cells and loss of neuroinvasiveness for weanling mice revealed further similarities between MVEV and the corresponding KUNV mutant. To confirm that the lack of detection of dimeric NS1 in mutant virus samples was not due to denaturation of unstable dimers during Western blotting, a mAb (2E3) specific for the MVEV NS1 homodimer was produced. When NS1 protein was fixed in mammalian and arthropod cells infected with wild-type or mutant virus, 2E3 reacted strongly with the former, but not the latter These results confirmed that Pro in NS1 is important for dimerization and that substitution of this residue by leucine represents a conserved marker of attenuation for viruses of the Japanese encephalitis virus serocomplex. The inability to detect dimeric NS1 in supernatant or cell monolayers of cultures productively infected with mutant virus also suggests that dimerization of the protein may not be essential for virus replication.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82609-0
2007-04-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/4/1175.html?itemId=/content/journal/jgv/10.1099/vir.0.82609-0&mimeType=html&fmt=ahah

References

  1. Arnold S. J., Osvath S. R., Hall R. A., King N. J., Sedger L. M. 2004; Regulation of antigen processing and presentation molecules in West Nile virus-infected human skin fibroblasts. Virology 324:286–296 [CrossRef]
    [Google Scholar]
  2. Blitvich B. J., Mackenzie J. S., Coelen R. J., Howard M. J., Hall R. A. 1995; A novel complex formed between the flavivirus E and NS1 proteins: analysis of its structure and function. Arch Virol 140:145–156 [CrossRef]
    [Google Scholar]
  3. Blitvich B. J., Scanlon D., Shiell B. J., Mackenzie J. S., Hall R. A. 1999; Identification and analysis of truncated and elongated species of the flavivirus NS1 protein. Virus Res 60:67–79 [CrossRef]
    [Google Scholar]
  4. Crooks A. J., Lee J. M., Easterbrook L. M., Timofeev A. V., Stephenson J. R. 1994; The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell. J Gen Virol 75:3453–3460 [CrossRef]
    [Google Scholar]
  5. Ellman G. L. 1959; Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77 [CrossRef]
    [Google Scholar]
  6. Fan W. F., Mason P. W. 1990; Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA. Virology 177:470–476 [CrossRef]
    [Google Scholar]
  7. Flamand M., Megret F., Mathieu M., Lepault J., Rey F. A., Deubel V. 1999; Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol 73:6104–6110
    [Google Scholar]
  8. Hall R. A., Burgess G. W., Kay B. H. 1988; Type-specific monoclonal antibodies produced to proteins of Murray Valley encephalitis virus. Immunol Cell Biol 66:51–56 [CrossRef]
    [Google Scholar]
  9. Hall R. A., Kay B. H., Burgess G. W., Clancy P., Fanning I. D. 1990; Epitope analysis of the envelope and nonstructural glycoproteins of Murray Valley encephalitis virus. J Gen Virol 71:2923–2930 [CrossRef]
    [Google Scholar]
  10. Hall R. A., Coelen R. J., Mackenzie J. S. 1991; Immunoaffinity purification of the NS1 protein of Murray Valley encephalitis virus: selection of the appropriate ligand and optimal conditions for elution. J Virol Methods 32:11–20 [CrossRef]
    [Google Scholar]
  11. Hall R. A., Brand T. N., Lobigs M., Sangster M. Y., Howard M. J., Mackenzie J. S. 1996; Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice. J Gen Virol 77:1287–1294 [CrossRef]
    [Google Scholar]
  12. Hall R. A., Khromykh A. A., Mackenzie J. M., Scherret J. H., Khromykh T. I., Mackenzie J. S. 1999; Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1. Virology 264:66–75 [CrossRef]
    [Google Scholar]
  13. Hall R. A., Broom A. K., Smith D. W., Mackenzie J. S. 2002; The ecology and epidemiology of Kunjin virus. Curr Top Microbiol Immunol 267:253–269
    [Google Scholar]
  14. Jacobs M. G., Robinson P. J., Bletchly C., Mackenzie J. M., Young P. R. 2000; Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J 14:1603–1610 [CrossRef]
    [Google Scholar]
  15. Lee E., Lobigs M. 2000; Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol 74:8867–8875 [CrossRef]
    [Google Scholar]
  16. Lee E., Lobigs M. 2002; Mechanism of virulence attenuation of GAG-binding variants of Japanese encephalitis and Murray Valley encephalitis viruses. J Virol 76:4901–4911 [CrossRef]
    [Google Scholar]
  17. Lee E., Hall R., Lobigs M. 2004; Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol 78:8271–8280 [CrossRef]
    [Google Scholar]
  18. Licon Luna R. M., Lee E., Müllbacher A., Blanden R. V., Langman R., Lobigs M. 2002; Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice. J Virol 76:3202–3211 [CrossRef]
    [Google Scholar]
  19. Lindenbach B. D., Rice C. M. 1997; trans -Complementation of YF virus NS1 reveals a role in early RNA replication. J Virol 71:9608–9617
    [Google Scholar]
  20. Lindenbach B. D., Rice C. M. 2001; Flaviviridae : the viruses and their replication. In Fields Virology pp 991–1041 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
    [Google Scholar]
  21. Lobigs M., Marshall I. D., Weir R. C., Dalgarno L. 1988; Murray Valley encephalitis virus field strain from Australian and Papua New Guinea. Studies on the sequence of the major envelope protein gene and virulence for mice. Virology 165:245–255 [CrossRef]
    [Google Scholar]
  22. Lobigs M., Müllbacher A., Wang Y., Pavy M., Lee E. 2003; Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. J Gen Virol 84:567–572 [CrossRef]
    [Google Scholar]
  23. Macdonald J., Tonry J., Hall R. A., Williams B., Palacios G., Ashok M. S., Jabado O., Clark D., Tesh R. B. other authors 2005; NS1 protein secretion during the acute phase of West Nile virus infection. J Virol 79:13924–13933 [CrossRef]
    [Google Scholar]
  24. Mackenzie J. S., Lindsay M. D., Coelen R. J., Broom A. K., Hall R. A., Smith D. W. 1994; Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol 136:447–467 [CrossRef]
    [Google Scholar]
  25. Mackenzie J. M., Jones M. K., Young P. R. 1996; Immunolocalization of the dengue viral nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220:232–240 [CrossRef]
    [Google Scholar]
  26. Mackenzie J. S., Johansen C. A., Ritchie S. A., van den Hurk A. F., Hall R. A. 2002; Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia. Curr Top Microbiol Immunol 267:49–73
    [Google Scholar]
  27. Mason P. W. 1989; Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. Virology 169:354–364 [CrossRef]
    [Google Scholar]
  28. May F. J., Lobigs M., Lee E., Gendle D. J., Mackenzie J. S., Broom A. K., Conlan J. V., Hall R. A. 2006; Biological, antigenic and phylogenetic characterization of the flavivirus Alfuy. J Gen Virol 87:329–337 [CrossRef]
    [Google Scholar]
  29. Müller U., Steinhoff U., Reis L. F., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. 1994; Functional role of type I and type II interferons in antiviral defense. Science 264:1918–1921 [CrossRef]
    [Google Scholar]
  30. Muylaert I. R., Galler R., Rice C. M. 1997; Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature sensitive mutation which blocks RNA accumulation. J Virol 71:291–298
    [Google Scholar]
  31. Schlesinger J. J., Brandriss M. W., Walsh E. E. 1985; Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol 135:2805–2809
    [Google Scholar]
  32. Schlesinger J. J., Brandriss M. W., Cropp C. B., Monath T. P. 1986; Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol 60:1153–1155
    [Google Scholar]
  33. Winkler G., Maxwell S. E., Ruemmler C., Stollar V. 1989; Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171:302–305 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82609-0
Loading
/content/journal/jgv/10.1099/vir.0.82609-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error